secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALTRIA GROUP, INC. (MO)
CIK:        0000764180
Form:       8-K
Filed at:   2022-10-20T23:59:59+00:00
Accession:  0001193125-22-265499
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.78
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Altria to assign IQOS U.S. rights to PMI for $2.7B cash, effective April 2024
-----------------------------------------------------------------------------

- Altria receives $1B immediately and $1.7B (plus 6% interest) by July 15, 2023 from PMI subsidiary Triaga.
- IQOS exclusive U.S. commercialization rights assigned to PMI effective April 30, 2024.
- IQOS currently unavailable in U.S. due to ITC import ban; PMI targets supply resumption in H1 2023.
- Altria will record $2.7B as deferred gain in Q4 2022, recognized in earnings upon assignment.
- Altria gains flexibility to invest in other smoke-free products; expects to finalize two product designs by end of 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/764180/000119312522265499/0001193125-22-265499-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/764180/000119312522265499/d361503d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-265499

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer